TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pfizer Anti-Infectives AB
Closing information (x1000 DKK)
| Closing information | 2023/11 | 2022/11 | 2021/11 |
| Turnover |
1,379,535
|
921,047
|
240,138 |
| Financial expenses |
0
|
321
|
921 |
| Earnings before taxes |
659,121
|
282,578
|
-412,125 |
| EBITDA |
680,139
|
323,188
|
-368,198 |
| Total assets |
1,639,273
|
1,075,813
|
830,257 |
| Current assets |
43,431
|
76,473
|
158,161 |
| Current liabilities |
493,133
|
425,854
|
375,932 |
| Equity capital |
1,146,141
|
649,959
|
454,325 |
| - share capital |
33
|
34
|
36 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Solvency |
69.9%
|
60.4%
|
54.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
47.8%
|
30.7%
|
-171.6% |
| Return on assets (ROA) |
40.2%
|
26.3%
|
-49.5% |
| Current ratio |
8.8%
|
18.0%
|
42.1% |
| Return on equity (ROE) |
57.5%
|
43.5%
|
-90.7% |
| Change turnover |
496,983
|
696,089
|
-870,267 |
| Change turnover % |
56%
|
309%
|
-78% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.